Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Roussou

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Haematologia|March 4, 2003
The prognostic role of CD5 negativity in B-cell chronic lymphocytic leukaemia: a case-control studyS Efstathiou, D Tsioulos, I Zacharos, et al.
European Journal of Haematology|November 15, 2002
The prognostic significance of CA 125 in patients with non-Hodgkin's lymphomaIoannis D Zacharos, Stamatis P Efstathiou, Elisa Petreli, et al.
Leukemia Research|December 23, 2003
Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survivalM G Alexandrakis, F H Passam, K Sfiridaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemiaM A Dimopoulos, G Hamilos, K Zervas, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Haematologia|March 4, 2003
The prognostic role of CD5 negativity in B-cell chronic lymphocytic leukaemia: a case-control studyS Efstathiou, D Tsioulos, I Zacharos, et al.
European Journal of Haematology|November 15, 2002
The prognostic significance of CA 125 in patients with non-Hodgkin's lymphomaIoannis D Zacharos, Stamatis P Efstathiou, Elisa Petreli, et al.
Leukemia Research|December 23, 2003
Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survivalM G Alexandrakis, F H Passam, K Sfiridaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemiaM A Dimopoulos, G Hamilos, K Zervas, et al.
Pageof 2